Biotech · Private company
Medicenna Therapeutics, Inc.
Track this companyFree. Adds Medicenna Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- MDNA11Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- MDNA55Phase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- Pembrolizumab (KEYTRUDA®)Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Beta-only IL-2 ImmunoTherapY StudyPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Aug 27, 2021ClinicalTrials.gov NCT05086692 · fetched Nov 12, 2026
- Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive GlioblastomaPHASE2 · COMPLETED · started Apr 11, 2017ClinicalTrials.gov NCT02858895 · fetched Nov 12, 2026